Fapon Biopharma, a biotech innovator in developing therapeutic antibodies and fusion proteins, is pleased to announce that ...

The U.S. Food and Drug Administration (FDA) has approved Fapon Biopharma’s Investigational New Drug (IND) application for ...

Continuous BG-labelled anti-ALCAM (C and E) and anti-ICAM1 (D and F ... A Scheme of flow cytometry analysis of cytokine production inside CD8 T cells stimulated by siRNA transfected EndoA3+ LB33-MEL ...

FP008 is designed for patients with solid tumors that have not responded to existing immunotherapies targeting PD-1.

Objectives To study the biology of the conventional T cells in human enthesis. Methods CD4+ and CD8+ T cells were investigated in 25 enthesis samples using immunofluorescence, cytometrically, bulk ...

Medicenna Therapeutics (MDNA) announced the presentation of new clinical data from its ongoing ABILITY-1 study evaluating MDNA11 alone or in ...

Introduction: CD8+ T cells infiltrate virtually every tissue to find and destroy infected or ... and 4-1BB (clone 17B5), CD127 (clone A7R34), CD25 (clone PC61.5), Eomes (clone Dan11mag), T-bet (clone ...

Methods: We combined single-cell RNA and T cell receptor sequencing with CITE-seq antibodies to characterize the CD8 + T cell response to SARS-CoV-2 infection at high resolution and compared responses ...

A six-month modified Atkins diet intervention in relapsing multiple sclerosis patients led to significant immunometabolic ...